Jefferies Financial Group Bets Big on Amgen Stock

Jefferies Financial Group Inc. has acquired a new position in shares of Amgen Inc. (NASDAQ: AMGN), a global biotechnology company focused on discovering, developing, manufacturing and delivering human therapeutics.

The firm purchased 239,779 shares of the medical research company's stock during the second quarter, valued at approximately $86,829,000. This represents about 0.6% of Jefferies Financial Group Inc.'s investment portfolio, making Amgen its 18th biggest holding.

Other institutional investors and hedge funds have also modified their holdings of AMGN in recent quarters. Anfield Capital Management LLC raised its stake by 1,000%, now owning 77 shares valued at $25,000 after buying an additional 70 shares in the last quarter.